StonvexLoading…
StonvexStonvexStonvexCore line items from QSI's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $2.44M | $3.06M | $1.08M | $0.00 |
Operating Income | $-116.10M | $-108.58M | $-111.17M | $-123.84M |
Net Income | $-101.34M | $-101.01M | $-95.96M | $-132.44M |
EPS (Diluted) | $-0.51 | $-0.71 | $-0.68 | $-0.95 |
Total Assets | $245.61M | $247.87M | $298.25M | $391.49M |
Total Liabilities | $25.38M | $32.45M | $26.63M | $32.78M |
Cash & Equivalents | $21.64M | $49.24M | $133.86M | $84.32M |
Free Cash Flow OCF − CapEx | $-97.23M | $-92.38M | $-98.55M | $-101.30M |
Shares Outstanding | 197.76M | 143.20M | 141.30M | 139.25M |